L. Shaw, H. Vanderstichele, M. Knapik-czajka, C. Clark, P. Aisen et al., Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects, Annals of Neurology, vol.55, issue.4, pp.403-413, 2009.
DOI : 10.1002/ana.21610
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2696350

N. Mattsson, H. Zetterberg, O. Hansson, N. Andreasen, L. Parnetti et al., CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment, JAMA, vol.302, issue.4, pp.385-393, 2009.
DOI : 10.1001/jama.2009.1064

J. Wiltfang, H. Esselmann, M. Bibl, M. Hüll, H. Hampel et al., Amyloid beta 20 A. Perret-Liaudet et al. / Alzheimer's Disease Biological Misdiagnosis peptide ratio 42, 2007.

B. Dubois, H. Feldman, C. Jacova, J. Cummings, S. Dekosky et al., Revising the definition of Alzheimer's disease: a new lexicon, The Lancet Neurology, vol.9, issue.11, pp.1118-1127, 2010.
DOI : 10.1016/S1474-4422(10)70223-4

N. Andreasen, C. Hesse, P. Davidsson, L. Minthon, A. Wallin et al., Cerebrospinal Fluid ??-Amyloid(1-42) in Alzheimer Disease, Archives of Neurology, vol.56, issue.6, pp.673-680, 1999.
DOI : 10.1001/archneur.56.6.673

N. Andreasen and K. Blennow, CSF biomarkers for mild cognitive impairment and early Alzheimer's disease, Clinical Neurology and Neurosurgery, vol.107, issue.3, pp.165-173, 2005.
DOI : 10.1016/j.clineuro.2004.10.011

M. Lorenzi, M. Donohue, D. Paternicò, C. Scarpazza, S. Ostrowitzki et al., Enrichment through biomarkers in clinical trials of Alzheimer's drugs in patients with mild cognitive impairment, Neurobiology of Aging, vol.31, issue.8, pp.1443-1451
DOI : 10.1016/j.neurobiolaging.2010.04.036

C. Teunissen, N. Verwey, M. Kester, K. Van-uffelen, and M. Blankenstein, Standardization of assay procedures for analysis of the CSF biomarkers amyloid beta(1-42), tau, and phosphorylated tau in Alzheimer's disease: Report of an international workshop, Int J Alzheimers Dis, p.635053, 2010.

N. Mattsson, U. Andreasson, S. Persson, H. Arai, S. Batish et al., The Alzheimer???s Association external quality control program for cerebrospinal fluid biomarkers, Alzheimer's & Dementia, vol.7, issue.4, pp.386-395, 2011.
DOI : 10.1016/j.jalz.2011.05.2243

M. Bjerke, E. Portelius, L. Minthon, A. Wallin, H. Anckarsäter et al., Confounding factors influencing amyloid beta concentration in cerebrospinal fluid Effect of sample collection tubes on cerebrospinal fluid concentrations of tau proteins and amyloid beta peptides, Int J Alzheimers Dis Clin Chem, vol.52, pp.332-334, 2006.

N. Andreasen, L. Minthon, P. Davidsson, E. Vanmechelen, H. Vanderstichele et al., Evaluation of CSF-tau and csf-abeta42 as diagnostic markers for Alzheimer disease in clinical practice, Arch Neurol, vol.58, pp.373-379, 2001.

J. Slemmon, J. Meredith, V. Guss, U. Andreasson, N. Andreasen et al., Measurement of A??1-42 in cerebrospinal fluid is influenced by matrix effects, Journal of Neurochemistry, vol.67, issue.2, pp.325-333, 2011.
DOI : 10.1111/j.1471-4159.2011.07553.x

A. Pica-mendez, M. Tanen, A. Dallob, W. Tanaka, and O. Laterza, Nonspecific binding of Abeta42 to polypropylene tubes and the effect of tween-20, Clin Chim Acta, vol.411, p.33, 2010.

A. Perret-liaudet, M. Pelpel, Y. Tholance, B. Dumont, H. Vanderstichele et al., Cerebrospinal Fluid Collection Tubes: A Critical Issue for Alzheimer Disease Diagnosis, Clinical Chemistry, vol.58, issue.4, pp.787-789, 2012.
DOI : 10.1373/clinchem.2011.178368
URL : https://hal.archives-ouvertes.fr/hal-00965203

B. Sweileh, Y. Hiari, M. Kailani, and H. Mohammad, Synthesis and Characterization of Polycarbonates by Melt Phase Interchange Reactions of Alkylene and Arylene Diacetates with Alkylene and Arylene Diphenyl Dicarbonates, Molecules, vol.15, issue.5, pp.3661-3682, 2010.
DOI : 10.3390/molecules15053661

K. Nakanishi, T. Sakiyama, and K. Imamura, On the adsorption of proteins on solid surfaces, a common but very complicated phenomenon, Journal of Bioscience and Bioengineering, vol.91, issue.3, pp.233-244, 2001.
DOI : 10.1016/S1389-1723(01)80127-4

A. Gabelle, S. Roche, C. Gény, K. Bennys, P. Labauge et al., Decreased sAPP,A38 and A40 cerebrospinal fluid levels in frontotemporal dementia, J Alzheimers Dis, vol.26, pp.553-563, 2011.

M. Duncan, J. Lee, and M. Warchol, Influence of surfactants upon protein/peptide adsorption to glass and polypropylene, International Journal of Pharmaceutics, vol.120, issue.2, pp.179-188, 1995.
DOI : 10.1016/0378-5173(94)00402-Q

F. Poncin-epaillard, C. Mille, D. Debarnot, W. Zorzi, B. Moualij et al., Study of the Adhesion of Neurodegenerative Proteins on Plasma-Modified and Coated Polypropylene Surfaces, Journal of Biomaterials Science, Polymer Edition, vol.ahead-of-print, issue.ahead-of-print, 2011.
DOI : 10.1163/156856211X598247

S. Zanini, C. Riccardi, E. Grimoldi, C. Colombo, A. Villa et al., Plasma-induced graft-polymerization of polyethylene glycol acrylate on polypropylene films: Chemical characterization and evaluation of the protein adsorption, Journal of Colloid and Interface Science, vol.341, issue.1, pp.53-58, 2010.
DOI : 10.1016/j.jcis.2009.09.012